Research demonstrates a synthetic antimicrobial peptide combats multidrug-resistant pathogens in wounds, suggesting improved chronic wound therapy.
Multidrug-resistant (MDR) pathogens are a major contributor to chronic and non-healing wound infections, where biofilms, high ionic strength and protease-rich exudates severely limit the performance of conventional antimicrobials. By 2050,...
No takes yet. Share an insight, caveat, or question.
Maan et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: